Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina

Table 2 Effects on the reduction of parenteral support in study cohorts

	Weekly PS volume (mL)	P value	Number of days per week with PS	P value
Adult cohort
Baseline	12000 (4663)	NA	4 (4-7)	NA
Week 12	8700 (3884)	0.00071	4 (4-5)	0.00482
Week 24	5705 (4514)	0.00014	3 (0-4)	0.00019
Pediatric cohort
Baseline	9090 (4954)	NA	6 (5-7)	NA
Week 12	7266 (5082)	0.00044	6 (4-6)	0.00143
Week 24	5491 (4433)	0.00002	5 (2-5)	0.00008

Weekly volume expressed as mean (SD); number of days per week expressed as median (1^st and 3^rd quartile). P value calculated by non-parametric method for paired data vs baseline; NA: Not applicable; PS: Parenteral support.